Tom Denee

The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study

Dena H. Jaffe, Benoît Rive, Tom Denee · BMC Psychiatry · 2019 · 238 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17

Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study

Flore Decuypere, Jan Sermon, Paul Geerts et al. · PLoS ONE · 2017 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

<p>The burden of suicidal ideation across Europe: a cross-sectional survey in five countries</p>

Dena H. Jaffe, Benoît Rive, Tom Denee · Neuropsychiatric Disease and Treatment · 2019 · 27 citations · Full text

Pharmacy, Health Sciences, Psychiatry +17

Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands

Thomas R. Einarson, Basil G. Bereza, Fadi Tedouri et al. · Journal of Medical Economics · 2017 · 24 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study

Shanaya Rathod, Tom Denee, Joe Eva et al. · Journal of Affective Disorders · 2021 · 23 citations · Full text

Pharmacy, Health Sciences, Psychiatry +17